Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Description

List of Tables

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

The global market for PCR POC consumables is expected to grow from $1.2 billion in 2024 to $1.6 billion by the end of 2029, at a CAGR of 6.1% from 2024 through 2029.

The global market for PCR POC analyzers is expected to grow from $360.1 million in 2024 to $465.5 million by the end of 2029, at a CAGR of 5.3% from 2024 through 2029.

Report Scope

This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.

The market is divided into segments and by application/industry:

By Product type:

POC PCR analyzers.
Consumables.

By analyte:

POC PCR analyzers.
Single analyte.
Multi-analyte.
Consumables.
Single analyte.
Multi-analyte.

By Application:

Infectious diseases.
Sexually transmitted diseases (STIs).
Other diseases.

Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.

Report Includes

53 data tables and 29 additional tables
An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment's future commercial potential
Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA's contribution to COVID-19 diagnostic testing
A review of patents and new developments in PCR POC technologies
Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN

Product Code: BIO157C

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Polymerase Chain Reaction Technology
Point of Care PCR Systems and Assays

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Market Opportunities
Market Restraints
Market Challenges

Chapter 4 Emerging Technologies and Developments

Overview
Instrument-Free PCR Tests
Five-Minute Point-of-Care Testing
Smartphone Enabled PCR System
Patents
Selected Patents

Chapter 5 Global Market for PCR POC Diagnostics

Segmentation Breakdown
Market Breakdown by Product Type
Market Breakdown by Analyte
PCR POC Analyzers by Analyte
PCR POC Consumables by Analyte
Market Breakdown by Application
Infectious Diseases
STIs
Geographic Breakdown
Market Breakdown by Region
North America
Latin America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Industry Scenario
Company Shares
Competitive Landscape Among Companies
Competitive Landscape in POC PCR Analyzers
Competitive Landscape in POC PCR Consumables

Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective

Introduction to ESG
Sustainability in Polymerase Chain Reaction for Point-of-Care Diagnostic Industry: An ESG Perspective
Key ESG Issues
ESG Performance Analysis
Concluding Remarks from BCC Research

Chapter 8 Appendix

Research Methodology
Acronyms
References
Company Profiles
ABBOTT
CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
QIAGEN
QUANTUMDX GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
VISBY MEDICAL INC.

Product Code: BIO157C

List of Tables

Summary Table : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, Through 2029
Table 1 : Global HIV Infections, 2022
Table 2 : People Living with HIV, by Region, 2022
Table 3 : Global Incidence of All Cancers, by Region, 2022-2050
Table 4 : Global Incidence of Leukemia, by Region, 2022-2050
Table 5 : Global Incidence of Hodgkin Lymphoma, by Region, 2022-2050
Table 6 : Global Incidence of Non-Hodgkin Lymphoma, by Region, 2022-2050
Table 7 : Global Incidence of Multiple Myeloma, by Region, 2022-2050
Table 8 : Selected Patents on PCR POC Technology, 2015-Present
Table 9 : Global Market for PCR POC Diagnostics, Through 2029
Table 10 : Global Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 11 : Global Market for PCR POC Analyzers, by Analyte, Through 2029
Table 12 : Global Market for Single Analyte PCR POC Analyzers, by Region, Through 2029
Table 13 : Global Market for Multi-Analyte PCR POC Analyzers , by Region, Through 2029
Table 14 : Global Market for PCR POC Consumables, by Analyte, Through 2029
Table 15 : Global Market for Single Analyte PCR POC Consumables, by Region, Through 2029
Table 16 : Global Market for Multi-Analyte PCR POC Consumables, by Region, Through 2029
Table 17 : Global Market for PCR for POC Diagnostics, by Application, Through 2029
Table 18 : Global Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 19 : Global Market for PCR POC Diagnostics in Infectious Diseases, by Region, Through 2029
Table 20 : North American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 21 : North American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 22 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 23 : Latin American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 24 : European Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 25 : European Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 26 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 27 : Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 28 : RoW Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 29 : Global Market for PCR POC Diagnostics in STIs, Through 2029
Table 30 : Global Market for PCR POC Diagnostics in STIs, by Region, Through 2029
Table 31 : North American Market for PCR POC Diagnostics in STIs, Through 2029
Table 32 : North American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 33 : Latin American Market for PCR POC Diagnostics in STIs, Through 2029
Table 34 : Latin American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 35 : European Market for PCR POC Diagnostics in STIs, Through 2029
Table 36 : European Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 37 : Asia-Pacific Market for PCR POC Diagnostics in STIs, Through 2029
Table 38 : Asia-Pacific Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 39 : RoW Market for PCR POC Diagnostics in STIs, Through 2029
Table 40 : Global Market for PCR for POC Diagnostics, by Region, Through 2029
Table 41 : North American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 42 : North American Market for PCR POC Diagnostics, by Country, Through 2029
Table 43 : Latin American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 44 : Latin American Market for PCR POC Diagnostics, by Country, Through 2029
Table 45 : European Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 46 : European Market for PCR POC Diagnostics, by Country, Through 2029
Table 47 : Asia-Pacific Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 48 : Asia-Pacific Market for PCR POC Diagnostics, by Country, Through 2029
Table 49 : RoW Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 50 : ESG: Environmental Overview
Table 51 : ESG: Social Overview
Table 52 : ESG: Governance Overview
Table 53 : ESG Rankings for Polymerase Chain Reaction Point-of-Care Diagnostics Companies, 2023*
Table 54 : Acronyms Used in This Report
Table 55 : Abbott: Company Snapshot
Table 56 : Abbott: Financial Performance, 2022 and 2023
Table 57 : Abbott: Product Portfolio
Table 58 : Abbott: News/Key Developments, 2022
Table 59 : Credo Diagnostics Biomedical Pte. Ltd.: Company Snapshot
Table 60 : Credo Diagnostics Biomedical Pte. Ltd.: Product Portfolio
Table 61 : Credo Diagnostics Biomedical Pte. Ltd.: News/Key Developments, 2022
Table 62 : Danaher Corp.: Company Snapshot
Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64 : Danaher Corp.: Product Portfolio
Table 65 : Danaher Corp.: News/Key Developments, 2023 and 2024
Table 66 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 67 : F. Hoffmann-La Roche Ltd.: Financial Performance, 2022 and 2023
Table 68 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 69 : QIAGEN: Company Snapshot
Table 70 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 71 : QIAGEN: Product Portfolio
Table 72 : QIAGEN: News/Key Developments, 2022
Table 73 : Quantumdx Group Ltd.: Company Snapshot
Table 74 : Quantumdx Group Ltd.: Product Portfolio
Table 75 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 76 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 77 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 78 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021
Table 79 : Visby Medical Inc.: Company Snapshot
Table 80 : Visby Medical Inc.: Product Portfolio
Table 81 : Visby Medical Inc.: News/Key Developments, 2023

List of Figures

Summary Figure A : Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2021-2029
Summary Figure B : Global Market Shares of Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2023
Figure 1 : Polymerase Chain Reaction for Point of Care Diagnostics: Market Dynamics
Figure 2 : Emerging Trends and Technologies in PCR for POC Diagnostics
Figure 3 : Global Market Shares of PCR POC Diagnostics, by Company, 2023
Figure 4 : Global Market Shares of POC PCR Analyzers, by Company, 2023
Figure 5 : Global Market Shares of POC PCR Consumables, by Company, 2023
Figure 6 : ESG Pillars
Figure 7 : Advantages of ESG for Companies
Figure 8 : Share of ESG Penetration in Polymerase Chain Reaction POC Diagnostics Market, 2023
Figure 9 : Abbott: Revenue Share, by Business Unit, 2023
Figure 10 : Abbott: Revenue Share, by Country/Region, 2023
Figure 11 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 12 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 13 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 14 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 15 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 16 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 18 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Emerging Technologies and Developments

Chapter 5 Global Market for PCR POC Diagnostics

Chapter 6 Competitive Intelligence

Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective

Chapter 8 Appendix

List of Tables

List of Figures